Umb Bank, N.A. Amgen Inc Transaction History

Umb Bank, N.A.

$6.22 Billion
Q4 2024

A detailed history of Umb Bank, N.A. transactions in Amgen Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 32,685 shares of AMGN stock, worth $10.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

32,685

Previous 34,918 6.39%

Holding current value

$10.1 Million

Previous $11.3 Million 24.28%

% of portfolio

0.14%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$258.78 - $328.31 $577,855 - $733,116	-2,233 Reduced 6.39%	32,685 $8.52 Million
Q3 2024 Oct 08, 2024	SELL	$309.38 - $337.38 $1.2 Million - $1.31 Million	-3,892 Reduced 10.03%	34,918 $11.3 Million
Q2 2024 Jul 29, 2024	SELL	$262.75 - $319.31 $1.08 Million - $1.31 Million	-4,118 Reduced 9.59%	38,810 $12.1 Million
Q1 2024 Apr 26, 2024	SELL	$268.87 - $324.56 $2.65 Million - $3.2 Million	-9,873 Reduced 18.7%	42,928 $12.2 Million
Q4 2023 Jan 23, 2024	SELL	$255.7 - $288.46 $1.3 Million - $1.47 Million	-5,079 Reduced 8.78%	52,801 $15.2 Million
Q3 2023 Oct 18, 2023	SELL	$218.65 - $271.46 $848,362 - $1.05 Million	-3,880 Reduced 6.28%	57,880 $15.6 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $13.2 Million - $15.6 Million	-61,412 Reduced 49.86%	61,760 $13.7 Million
Q1 2023 Apr 11, 2023	BUY	$225.79 - $275.2 $420,195 - $512,147	1,861 Added 1.53%	123,172 $29.8 Million
Q4 2022 Jan 10, 2023	BUY	$229.03 - $291.01 $14.2 Million - $18 Million	61,858 Added 104.05%	121,311 $31.9 Million
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $735,555 - $829,572	-3,277 Reduced 5.22%	59,453 $13.4 Million
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $98,743 - $109,884	428 Added 0.69%	62,730 $15.3 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $506,513 - $560,336	2,310 Added 3.85%	62,302 $15.1 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $1.6 Million - $1.83 Million	8,062 Added 15.52%	59,992 $13.5 Million
Q3 2021 Oct 18, 2021	BUY	$212.27 - $248.7 $19,528 - $22,880	92 Added 0.18%	51,930 $11 Million
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $32,000 - $35,502	-137 Reduced 0.26%	51,838 $12.6 Million
Q1 2021 Apr 15, 2021	BUY	$221.91 - $258.6 $98,971 - $115,335	446 Added 0.87%	51,975 $12.9 Million
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $2.2 Million - $2.62 Million	-10,157 Reduced 16.47%	51,529 $11.8 Million
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $462,281 - $567,283	-2,337 Reduced 3.65%	61,686 $14.5 Million
Q1 2020 May 26, 2020	SELL	$182.24 - $241.7 $173,128 - $229,615	-950 Reduced 1.46%	64,023 $13 Million
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $257,704 - $331,238	1,362 Added 2.14%	64,973 $15.7 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $889,527 - $1.07 Million	-5,109 Reduced 7.43%	63,611 $12.3 Million
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $13.1 Million - $15.4 Million	-78,743 Reduced 53.4%	68,720 $12.7 Million
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $229,885 - $259,131	-1,271 Reduced 0.85%	147,463 $28 Million
Q4 2018 Jan 24, 2019	BUY	$178.4 - $208.25 $2.42 Million - $2.83 Million	13,589 Added 10.06%	148,734 $29 Million
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $482,309 - $543,740	2,603 Added 1.96%	135,145 $28 Million
Q2 2018 Jul 31, 2018	BUY	$166.05 - $186.51 $442,523 - $497,049	2,665 Added 2.05%	132,542 $24.5 Million
Q1 2018 Apr 25, 2018	BUY	$169.43 - $198.0 $597,918 - $698,742	3,529 Added 2.79%	129,877 $22.1 Million
Q4 2017 Jan 22, 2018	BUY	$168.79 - $188.59 $445,943 - $498,254	2,642 Added 2.14%	126,348 $22 Million
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $20.7 Million - $23.6 Million	123,706	123,706 $23.1 Million

Others Institutions Holding AMGN

# of Institutions

3,166

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account